# A Study of BCMA-directed CAR-T Cells Treatment in Subjects With r/r Multiple Myeloma

> **NCT04295018** · PHASE1 · UNKNOWN · sponsor: **Peking Union Medical College Hospital** · enrollment: 10 (estimated)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** C-CAR088

## Key facts

- **NCT ID:** NCT04295018
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-10-23
- **Primary completion:** 2021-09
- **Final completion:** 2021-12
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2020-03-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04295018

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04295018, "A Study of BCMA-directed CAR-T Cells Treatment in Subjects With r/r Multiple Myeloma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04295018. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*